This SOP establishes the requirements for selecting and verifying component vendors—including authentication of manufacturers, repackagers, and wholesale distributors; compliance with DSCSA and FDA registration; review of licenses, accreditations, and warning letters; evaluation of APIs, excipients, and OTC vendors; and ongoing vendor monitoring—to ensure product integrity, prevent counterfeit or diverted drugs, and maintain compliance with USP <797> and federal regulations.